What to Tell GLP-1 Patients Who Aren’t Losing as Much Weight
Comparing one’s results with others’ is natural, but not necessarily helpful or fair. Medscape Medical News
How to Help Your Patients With a GLP-1 Exit Plan
No matter why a patient decides to stop using the popular drugs, be ready to help them transition and stay healthy. Medscape Medical News
Explaining Skin Laxity After Drastic GLP-1 Weight Loss
There are cosmetic, psychological, and physical complications that can come from rapid weight loss. Medscape Medical News
Molecular and Computational Characterization of GLP-1 Receptor–Agonist Binding Mechanisms for Rational Therapeutic Design
Obesity is one of the fastest-growing global health crises, fueling diabetes, cardiovascular disease, and reduced life expectancy. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide, semaglutide, exenatide, and Lixisenatide, have transformed treatment; however, their injection-based delivery, high cost, and side effects limit accessibility. A deeper structural understanding of GLP-1 receptor binding is needed to guide […]
GoodRx Launches $199 Ozempic and Wegovy Pricing, Unveils Telemedicine for GLP-1 Access
What You Should Know: – GoodRx has unveiled two major initiatives to democratize access to GLP-1 medications: the launch of the GoodRx for Weight Loss telemedicine subscription and a new introductory cash price of $199 per month for Ozempic® and Wegovy® injection pens through a partnership with Novo Nordisk. GoodRx for Weight Loss Telemedicine GoodRx […]
GLP-1 weight-loss treatment is being used for alcohol and drug addiction
submitted by /u/Successful-Peach-764 [link] [comments]
Obesity drugs: Will Trump’s plan lower costs?
President Trump wants to “make America slim again,” said Kara Kennedy in The Free Press. Standing beside drug execs in the Oval Office earlier this month, Trump announced deals with Eli Lilly and Novo Nordisk that will cut the price of their GLP-1 weight loss medicines, Zepbound and Wegovy, in return for a three-year exemption […]
Lala Kent Details ‘Nightmare’ Co-Parenting Situation with Ex Randall Emmett
Lala Kent admits that co-parenting 4-year-old daughter Ocean with ex Randall Emmett is not going well – Page Six Robbie Williams claims taking a GLP-1 has caused blurry vision and blindness – Celebitchy Patrick Mahomes reacts to Travis Kelce breaking a Chiefs record – E! News RHOP‘s Karen Huger is speaking out for the first […]
Novo Nordisk: Modeling A GLP-1 Giant In Retreat And Recovery
How Mounjaro Alters Craving Circuits in the Brain
A rare intracranial brain-recording study revealed that tirzepatide, a GLP-1 and GIP receptor agonist, temporarily silences craving-related neural activity in a key reward circuit of the brain. Using implanted electrodes in a patient with treatment-resistant obesity and loss of control eating, researchers observed that the drug initially shut down signaling in the nucleus accumbens.